Ensysce Biosciences, Inc. Quarterly Depreciation in USD from Q2 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ensysce Biosciences, Inc. quarterly/annual Depreciation history and growth rate from Q2 2020 to Q2 2025.
  • Ensysce Biosciences, Inc. Depreciation for the quarter ending June 30, 2025 was $0.000.
  • Ensysce Biosciences, Inc. annual Depreciation for 2024 was $0.000.
  • Ensysce Biosciences, Inc. annual Depreciation for 2023 was $0.000.
  • Ensysce Biosciences, Inc. annual Depreciation for 2022 was $0.000, a 100% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $0 $0 Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $0 $0 Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q2 2024 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2021 $151 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $50.00 $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $50.00 $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $51.00 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $50.00 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $50.00 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.